Has the global prevalence of Helicobacter pylori (H. pylori) decreased?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, the global prevalence of Helicobacter pylori (H. pylori) has decreased, particularly in developed countries, due to improved sanitation, better hygiene practices, and increased use of antibiotics. This decline is attributed to several factors, including socioeconomic improvements leading to better living conditions, which have played a significant role in reducing transmission, primarily occurring through oral-oral or fecal-oral routes during childhood 1. The decreasing prevalence correlates with declining rates of peptic ulcer disease and gastric cancer in many regions, as H. pylori is a major risk factor for these conditions.

Some key points to consider:

  • In developed nations, prevalence rates have dropped from 30-40% to 10-20% in many populations, though rates remain higher in developing countries (40-80%) 1.
  • H. pylori remains one of the most common bacterial infections worldwide, affecting approximately 4.4 billion people globally 1.
  • The decline in H. pylori prevalence may also be linked to increasing rates of conditions like asthma, allergies, and esophageal diseases, supporting the "hygiene hypothesis" that suggests some bacterial exposures may protect against certain immune-mediated disorders.
  • Countries with a high prevalence of gastric cancer, such as Japan, Korea, Taiwan, and China, have either introduced or are planning to introduce population-wide H. pylori eradication programs, especially designed to eliminate gastric cancer 1.

Overall, the global decline in H. pylori prevalence is a positive trend, but it is essential to continue monitoring and addressing the remaining high-prevalence areas, as well as the potential consequences of decreasing H. pylori exposure on other health conditions 1.

From the Research

Global Prevalence of H. pylori

  • The provided studies do not directly address the global prevalence of H. pylori over time 2, 3, 4, 5, 6.
  • However, the studies discuss the current management and treatment strategies for H. pylori infection, suggesting that it remains a significant health concern worldwide 2, 3, 4, 5, 6.
  • The fact that H. pylori infection is still a common cause of peptic ulcer disease and other gastrointestinal disorders implies that its prevalence may not have decreased significantly 3, 4, 6.
  • Nevertheless, there is no explicit information in the provided studies to confirm whether the global prevalence of H. pylori has decreased or remained stable over time.

H. pylori Infection and Treatment

  • The studies emphasize the importance of diagnosing and treating H. pylori infection to prevent complications such as peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric cancer 2, 3, 4, 5, 6.
  • The "test-and-treat" strategy is recommended for managing H. pylori infection, especially in patients with dyspepsia and no alarm symptoms 3, 4, 6.
  • The choice of treatment depends on various factors, including antibiotic resistance patterns, patient age, and medication use 2, 3, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Guidelines in the medical treatment of Helicobacter pylori infection.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006

Research

Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.

Canadian family physician Medecin de famille canadien, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.